11/23/2020 • Publication
Lancet publishes paper on the Visby Medical point-of-care PCR technology
A study of the performance of the Visby Medical Sexual Health Test, a single-use, point-of-care PCR device.
Authors: Sheldon R Morris, MD; Claire C Bristow, PhD; Michael R Wierzbicki, PhD; Mark Sarno, eJD; Lenore Asbel, MD; Audrey French, MD; Charlotte A Gaydos, DrPH; Lydie Hazan, MD; Leandro Mena, MD; Purnima Madhivanan, MD; Susan Philip, MD; Saara Schwartz, MD; Constance Brown, MD; David Styers, BS; Toni Waymer, BA; Jeffrey D Klausner, MD
Published: November 23, 2020
Summary:
Background
Methods
Findings
Interpretation
Funding
See the full article here:
Read more articles & insights
Everything You Need to Know about Trichomonas Featuring Dr. Ina Park
CME on-demand webinar presented by ASHA | A comprehensive guide for the detection and management of the often neglected sexually transmitted infection, Trichomoniasis.
Navigating the Post-Public Health Emergency Landscape: How the Visby Medical Respiratory Health Test EUA Remains Unaffected
As we move into the post-public health emergency landscape with the expiration of the national emergency concerning the coronavirus disease 2019 (COVID-19) pandemic on May
Visby Medical™ Receives FDA Clearance and CLIA Waiver for second Generation Sexual Health Test for Women
Visby Medical™ announced today that it has received 510(k) clearance and was granted a CLIA waiver from the FDA for its 2nd generation point of
Visby Medical Receives FDA Emergency Use Authorization for Respiratory Health Test for Use in CLIA Waived Settings
Visby Medical announced today that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for its Respiratory Health point of